-
1
-
-
0015137207
-
The need for a standardised cell substrate for virus vaccine production
-
Perkins, F.T. (1971) The need for a standardised cell substrate for virus vaccine production. Jpn. J. Med. Sci. Biol., 24, 329-344.
-
(1971)
Jpn. J. Med. Sci. Biol.
, vol.24
, pp. 329-344
-
-
Perkins, F.T.1
-
2
-
-
0002963116
-
Cultivation of Lansing strain of poliomyelitis virus in culture of various human embryonic tissues
-
Enders, J.F., Weller, T.H., and Robbins, F.C. (1949) Cultivation of Lansing strain of poliomyelitis virus in culture of various human embryonic tissues. Science, 109, 85-87.
-
(1949)
Science
, vol.109
, pp. 85-87
-
-
Enders, J.F.1
Weller, T.H.2
Robbins, F.C.3
-
3
-
-
0025602722
-
Production of poliovirus vaccines: past, present, and future
-
Duchene, M., Peetermans, J., D'Hondt, E., Harford, N. et al. (1990) Production of poliovirus vaccines: past, present, and future. Viral. Immunol., 3, 243-272.
-
(1990)
Viral. Immunol.
, vol.3
, pp. 243-272
-
-
Duchene, M.1
Peetermans, J.2
D'Hondt, E.3
Harford, N.4
-
4
-
-
0038041729
-
Annex 2. Recommendations for the production and control of poliomyelitis vaccine (inactivated)
-
WHO Technical Report Series, No. 910
-
World Heath Organisation (2002) Annex 2. Recommendations for the production and control of poliomyelitis vaccine (inactivated). WHO Technical Report Series, No. 910.
-
(2002)
-
-
-
5
-
-
85192416489
-
Annex 2. Guidelines for the safe production and quality control of inactivated poliomyelitis vaccine manufactured from wild polioviruses (Addendum, 2003, to the Recommendations for the Production and Quality Control of Poliomyelitis Vaccine (Inactivated)
-
WHO Technical Report Series, No. 926
-
World Heath Organisation (2004) Annex 2. Guidelines for the safe production and quality control of inactivated poliomyelitis vaccine manufactured from wild polioviruses (Addendum, 2003, to the Recommendations for the Production and Quality Control of Poliomyelitis Vaccine (Inactivated). WHO Technical Report Series, No. 926.
-
(2004)
-
-
-
6
-
-
84902042230
-
-
Vaccines, 6th edn (eds S.A. Plotkin, W.A. Orenstein, and P.A. Offit), Elsevier Saunders, Philadelphia
-
Vidor, E. and Plotkin, S.A. (2013) Poliovirus Vaccine-Inactivated, in Vaccines, 6th edn (eds S.A. Plotkin, W.A. Orenstein, and P.A. Offit), Elsevier Saunders, Philadelphia, pp. 573-597.
-
(2013)
Poliovirus Vaccine-Inactivated
, pp. 573-597
-
-
Vidor, E.1
Plotkin, S.A.2
-
7
-
-
0038451074
-
Monolayer Growth Systems: Multiple Processes
-
eds R.E. Spier and J.B. Griffiths), Academic Press, London
-
Panina, G.F. (1985) Monolayer Growth Systems: Multiple Processes, in Animal Cell Biotechnology, vol. 1 (eds R.E. Spier and J.B. Griffiths), Academic Press, London, pp. 211-242.
-
(1985)
Animal Cell Biotechnology
, vol.1
, pp. 211-242
-
-
Panina, G.F.1
-
8
-
-
0343316251
-
Monolayer Growth Systems: Heterogeneous Unit Processes
-
eds R.E. Spier and J.B. Griffiths), Academic Press, London
-
Spier, R.E. (1985) Monolayer Growth Systems: Heterogeneous Unit Processes, in Animal Cell Biotechnology, vol. 1 (eds R.E. Spier and J.B. Griffiths), Academic Press, London, pp. 243-263.
-
(1985)
Animal Cell Biotechnology
, vol.1
, pp. 243-263
-
-
Spier, R.E.1
-
9
-
-
0028616930
-
Cultivation of attenuated hepatitis A virus antigen in a titanium static mixer reactor
-
Junker, B.H., Seamans, T.C., Ramasubramanyan, K., Aunins, J. et al. (1994) Cultivation of attenuated hepatitis A virus antigen in a titanium static mixer reactor. Biotechnol. Bioeng., 44, 1315-1324.
-
(1994)
Biotechnol. Bioeng.
, vol.44
, pp. 1315-1324
-
-
Junker, B.H.1
Seamans, T.C.2
Ramasubramanyan, K.3
Aunins, J.4
-
10
-
-
0038451074
-
Monolayer Growth Systems: Homogeneous Unit Processes
-
(eds R.E. Spier and J.B. Griffiths), Academic Press, London
-
Van Wezel, A.L. (1985) Monolayer Growth Systems: Homogeneous Unit Processes, in Animal Cell Biotechnology, vol. 1 (eds R.E. Spier and J.B. Griffiths), Academic Press, London, pp. 265-282.
-
(1985)
Animal Cell Biotechnology
, vol.1
, pp. 265-282
-
-
Van Wezel, A.L.1
-
11
-
-
0027014522
-
Evaluation of a microcarrier process for large-scale cultivation of attenuated hepatitis A
-
Junker, B.H., Wu, F., Wang, S., Waterbury, J. et al. (1992) Evaluation of a microcarrier process for large-scale cultivation of attenuated hepatitis A. Cytotechnology, 9, 173-187.
-
(1992)
Cytotechnology
, vol.9
, pp. 173-187
-
-
Junker, B.H.1
Wu, F.2
Wang, S.3
Waterbury, J.4
-
12
-
-
0021274411
-
Thousand liter scale microcarriers culture of Vero cells for killed polio virus vaccine. Promising results
-
Montagnon, B.J., Fanget, B., and Vincent-Falquet, J.C. (1984) Thousand liter scale microcarriers culture of Vero cells for killed polio virus vaccine. Promising results. Dev. Biol. Stand., 55, 37-42.
-
(1984)
Dev. Biol. Stand.
, vol.55
, pp. 37-42
-
-
Montagnon, B.J.1
Fanget, B.2
Vincent-Falquet, J.C.3
-
13
-
-
65649125562
-
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
-
Barrett, P.N., Mundt, W., Kistner, O., and Howard, M.K. (2009) Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev. Vaccines, 8, 607-618.
-
(2009)
Expert Rev. Vaccines
, vol.8
, pp. 607-618
-
-
Barrett, P.N.1
Mundt, W.2
Kistner, O.3
Howard, M.K.4
-
14
-
-
0023092907
-
Hydrodynamic effects on animal cells grown in microcarrier cultures
-
Croughan, M.S., Hamel, J.F., and Wang, D.I. (1987) Hydrodynamic effects on animal cells grown in microcarrier cultures. Biotechnol. Bioeng., 29, 130-141.
-
(1987)
Biotechnol. Bioeng.
, vol.29
, pp. 130-141
-
-
Croughan, M.S.1
Hamel, J.F.2
Wang, D.I.3
-
15
-
-
0022059389
-
A mechanistic analysis of the inoculum requirement for the cultivation of mammalian cells on microcarriers
-
Hu, W.S., Meier, J., and Wang, D.I.C. (1985) A mechanistic analysis of the inoculum requirement for the cultivation of mammalian cells on microcarriers. Biotechnol. Bioeng., 27, 585-595.
-
(1985)
Biotechnol. Bioeng.
, vol.27
, pp. 585-595
-
-
Hu, W.S.1
Meier, J.2
Wang, D.I.C.3
-
16
-
-
84865137382
-
Cell Detachment
-
ed. M.C. Flickinger), John Wiley & Sons, Inc., Hoboken
-
Merten, O.-W. (2010) Cell Detachment, in Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology (ed. M.C. Flickinger), John Wiley & Sons, Inc., Hoboken, pp. 1-22.
-
(2010)
Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology
, pp. 1-22
-
-
Merten, O.-W.1
-
17
-
-
33747369005
-
Introduction to animal cell culture technology - past, present and future
-
Merten, O.-W. (2006) Introduction to animal cell culture technology - past, present and future. Cytotechnology, 50, 1-7.
-
(2006)
Cytotechnology
, vol.50
, pp. 1-7
-
-
Merten, O.-W.1
-
18
-
-
0014195418
-
Growth of cellstrains and primary cells on micro-carriers in homogeneous culture
-
Van Wezel, A.L. (1967) Growth of cellstrains and primary cells on micro-carriers in homogeneous culture. Nature, 216, 64-65.
-
(1967)
Nature
, vol.216
, pp. 64-65
-
-
Van Wezel, A.L.1
-
19
-
-
0030042880
-
Production of Influenza Virus in Cell Cultures for Vaccine Preparation
-
eds S. Cohen and A. Shafferman), Plenum Press, New York
-
Merten, O.-W., Hannoun, C., Manuguerra, J.-C., Ventre, F. et al. (1996) Production of Influenza Virus in Cell Cultures for Vaccine Preparation, in Novel Strategies in the Design and Production of Vaccines (eds S. Cohen and A. Shafferman), Plenum Press, New York, pp. 141-151.
-
(1996)
Novel Strategies in the Design and Production of Vaccines
, pp. 141-151
-
-
Merten, O.-W.1
Hannoun, C.2
Manuguerra, J.-C.3
Ventre, F.4
-
20
-
-
0032618632
-
InfluvacTC: a safe Madin Darby canine kidney (MDCK) cell culturebased influenza vaccine
-
discussion 111
-
Brands, R., Visser, J., Medema, J., Palache, A.M. et al. (1999) InfluvacTC: a safe Madin Darby canine kidney (MDCK) cell culturebased influenza vaccine. Dev. Biol. Stand., 98, 93-100; discussion 111.
-
(1999)
Dev. Biol. Stand.
, vol.98
, pp. 93-100
-
-
Brands, R.1
Visser, J.2
Medema, J.3
Palache, A.M.4
-
21
-
-
70350154349
-
Suspension-Vero cell cultures as a platform for viral vaccine production
-
Paillet, C., Forno, G., Kratje, R., and Etcheverrigaray, M. (2009) Suspension-Vero cell cultures as a platform for viral vaccine production. Vaccine, 27, 6464-6467.
-
(2009)
Vaccine
, vol.27
, pp. 6464-6467
-
-
Paillet, C.1
Forno, G.2
Kratje, R.3
Etcheverrigaray, M.4
-
22
-
-
77955664960
-
Animal cells and processes for the replication of influenza viruses
-
World pat. WO 97/ 37000, filed 1 April 1997 and issued 9 October 1997
-
Gröner, A. and Vorlop, J. (1997) Animal cells and processes for the replication of influenza viruses. World pat. WO 97/ 37000, filed 1 April 1997 and issued 9 October 1997.
-
(1997)
-
-
Gröner, A.1
Vorlop, J.2
-
23
-
-
33644622434
-
Tumorigenicity assessments of Per. C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line
-
discussion 265-266
-
Ledwith, B.J., Lanning, C.L., Gumprecht, L.A., Anderson, C.A. et al. (2006) Tumorigenicity assessments of Per. C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line. Dev. Biol. (Basel), 123, 251-263; discussion 265-266.
-
(2006)
Dev. Biol. (Basel)
, vol.123
, pp. 251-263
-
-
Ledwith, B.J.1
Lanning, C.L.2
Gumprecht, L.A.3
Anderson, C.A.4
-
24
-
-
84872602323
-
PER.C6(1) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine
-
Sanders, B.P., Edo-Matas, D., Custers, J.H., Koldijk, M.H. et al. (2013) PER.C6(1) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine. Vaccine, 31, 850-856.
-
(2013)
Vaccine
, vol.31
, pp. 850-856
-
-
Sanders, B.P.1
Edo-Matas, D.2
Custers, J.H.3
Koldijk, M.H.4
-
25
-
-
0034633740
-
Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production
-
Schiedner, G., Hertel, S., and Kochanek, S. (2000) Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum. Gene Ther., 11, 2105-2116.
-
(2000)
Hum. Gene Ther.
, vol.11
, pp. 2105-2116
-
-
Schiedner, G.1
Hertel, S.2
Kochanek, S.3
-
26
-
-
40449122158
-
Efficient and reproducible generation of highexpressing, stable human cell lines without need for antibiotic selection
-
Schiedner, G., Hertel, S., Bialek, C., Kewes, H. et al. (2008) Efficient and reproducible generation of highexpressing, stable human cell lines without need for antibiotic selection. BMC Biotechnol., 8, 13.
-
(2008)
BMC Biotechnol.
, vol.8
, pp. 13
-
-
Schiedner, G.1
Hertel, S.2
Bialek, C.3
Kewes, H.4
-
27
-
-
78149319046
-
The avian EB66(R) cell line, application to vaccines, and therapeutic protein production
-
Brown, S.W. and Mehtali, M. (2010) The avian EB66(R) cell line, application to vaccines, and therapeutic protein production. PDA J. Pharm. Sci. Technol., 64, 419-425.
-
(2010)
PDA J. Pharm. Sci. Technol.
, vol.64
, pp. 419-425
-
-
Brown, S.W.1
Mehtali, M.2
-
28
-
-
58249123674
-
An avian cell line designed for production of highly attenuated viruses
-
Jordan, I., Vos, A., Beilfuss, S., Neubert, A. et al. (2009) An avian cell line designed for production of highly attenuated viruses. Vaccine, 27, 748-756.
-
(2009)
Vaccine
, vol.27
, pp. 748-756
-
-
Jordan, I.1
Vos, A.2
Beilfuss, S.3
Neubert, A.4
-
29
-
-
67650430190
-
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation
-
Lohr, V., Rath, A., Genzel, Y., Jordan, I. et al. (2009) New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine, 27, 4975-4982.
-
(2009)
Vaccine
, vol.27
, pp. 4975-4982
-
-
Lohr, V.1
Rath, A.2
Genzel, Y.3
Jordan, I.4
-
30
-
-
84870065670
-
Avial Designer Cells AGE1. CR1 as Candidates for MVA and Influenza Vaccine Production
-
eds N. Jenkins, N. Barron, and P. Alves), ESACT Proceedings, Springer, Berlin
-
Lohr, V., Rath, A., Jordan, I., Sandig, V. et al. (2012) Avial Designer Cells AGE1. CR1 as Candidates for MVA and Influenza Vaccine Production, in Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009 (eds N. Jenkins, N. Barron, and P. Alves), ESACT Proceedings, vol. 5, Springer, Berlin, 615-631.
-
(2012)
Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009
, vol.5
, pp. 615-631
-
-
Lohr, V.1
Rath, A.2
Jordan, I.3
Sandig, V.4
-
31
-
-
84875957468
-
Avian cell line -technology for large scale vaccine production
-
Kraus, B., von Fricks, S., Feigl, S., Koch, S.M. et al. (2011) Avian cell line -technology for large scale vaccine production. BMC Proc., 5 (Suppl 8), P52.
-
(2011)
BMC Proc.
, vol.5
, pp. 52
-
-
Kraus, B.1
von Fricks, S.2
Feigl, S.3
Koch, S.M.4
-
33
-
-
77949412710
-
Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection
-
Prabakaran, M., Madhan, S., Prabhu, N., Qiang, J. et al. (2010) Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. J. Virol., 84, 3201-3209.
-
(2010)
J. Virol.
, vol.84
, pp. 3201-3209
-
-
Prabakaran, M.1
Madhan, S.2
Prabhu, N.3
Qiang, J.4
-
34
-
-
0000352666
-
Growth of a cloned strain of hamster kidney cells in suspended cultures and their susceptibility to the virus of foot and mouth disease
-
Capstick, P.B., Telling, R.C., Chapman, W.G., and Stewart, D.L. (1962) Growth of a cloned strain of hamster kidney cells in suspended cultures and their susceptibility to the virus of foot and mouth disease. Nature, 195, 1163-1164.
-
(1962)
Nature
, vol.195
, pp. 1163-1164
-
-
Capstick, P.B.1
Telling, R.C.2
Chapman, W.G.3
Stewart, D.L.4
-
35
-
-
0021775727
-
Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process
-
Pay, T.W.F., Boge, A., Menard, F.J.R.R., and Radlett, P.J. (1985) Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process. Dev. Biol. Stand., 60, 171-174.
-
(1985)
Dev. Biol. Stand.
, vol.60
, pp. 171-174
-
-
Pay, T.W.F.1
Boge, A.2
Menard, F.J.R.R.3
Radlett, P.J.4
-
36
-
-
84859408710
-
Introducing yesterday's phage therapy in today's medicine
-
Pirnay, J.-P., Verbeken, G., Rose, T., Jennes, S. et al. (2012) Introducing yesterday's phage therapy in today's medicine. Future Virol., 7, 379-390.
-
(2012)
Future Virol.
, vol.7
, pp. 379-390
-
-
Pirnay, J.-P.1
Verbeken, G.2
Rose, T.3
Jennes, S.4
-
37
-
-
85192405234
-
Global Eradication of Poliomyelitis the Year 2000, World Health Assembly Resolution WHA41.28
-
Geneva, Switzerland
-
World Health Organization (1988) Global Eradication of Poliomyelitis the Year 2000, World Health Assembly Resolution WHA41.28, Geneva, Switzerland.
-
(1988)
-
-
-
38
-
-
0036204143
-
Vaccineassociated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine
-
Kohler, K.A., Banerjee, K., Gary Hlady, W., Andrus, J.K. et al. (2002) Vaccineassociated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull. World Health Org., 80, 210-216.
-
(2002)
Bull. World Health Org.
, vol.80
, pp. 210-216
-
-
Kohler, K.A.1
Banerjee, K.2
Gary Hlady, W.3
Andrus, J.K.4
-
39
-
-
77952320069
-
The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox
-
Heinsbroek, E. and Ruitenberg, E.J. (2010) The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox. Vaccine, 28, 3778-3783.
-
(2010)
Vaccine
, vol.28
, pp. 3778-3783
-
-
Heinsbroek, E.1
Ruitenberg, E.J.2
-
40
-
-
78649323066
-
Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues
-
Barallon, R., Bauer, S.R., Butler, J., Capes-Davis, A. et al. (2010) Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev. Biol. Anim., 46, 727-732.
-
(2010)
In Vitro Cell Dev. Biol. Anim.
, vol.46
, pp. 727-732
-
-
Barallon, R.1
Bauer, S.R.2
Butler, J.3
Capes-Davis, A.4
-
41
-
-
84858700318
-
Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines
-
Hess, R.D., Weber, F., Watson, K., and Schmitt, S. (2012) Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Vaccine, 30, 2715-2727.
-
(2012)
Vaccine
, vol.30
, pp. 2715-2727
-
-
Hess, R.D.1
Weber, F.2
Watson, K.3
Schmitt, S.4
-
42
-
-
56949097741
-
An overview of animal cell substrates for biological products
-
Petricciani, J. and Sheets, R. (2008) An overview of animal cell substrates for biological products. Biologicals, 36, 359-362.
-
(2008)
Biologicals
, vol.36
, pp. 359-362
-
-
Petricciani, J.1
Sheets, R.2
-
43
-
-
0019203184
-
Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation
-
Montagnon, B.J., Nicolas, A.J., Fanget, B., and Peyron, L. (1981) Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation. Dev. Biol. Stand., 47, 151-155.
-
(1981)
Dev. Biol. Stand.
, vol.47
, pp. 151-155
-
-
Montagnon, B.J.1
Nicolas, A.J.2
Fanget, B.3
Peyron, L.4
-
44
-
-
84875516309
-
Scale-down of the inactivated polio vaccine production process
-
Thomassen, Y.E., van't Oever, A.G., Vinke, M., Spiekstra, A. et al. (2013) Scale-down of the inactivated polio vaccine production process. Biotechnol. Bioeng., 110, 1354-1365.
-
(2013)
Biotechnol. Bioeng.
, vol.110
, pp. 1354-1365
-
-
Thomassen, Y.E.1
van't Oever, A.G.2
Vinke, M.3
Spiekstra, A.4
-
45
-
-
80052447900
-
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
-
Bakker, W.A., Thomassen, Y.E., van't Oever, A.G., Westdijk, J. et al. (2011) Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. Vaccine, 29, 7188-7196.
-
(2011)
Vaccine
, vol.29
, pp. 7188-7196
-
-
Bakker, W.A.1
Thomassen, Y.E.2
van't Oever, A.G.3
Westdijk, J.4
-
46
-
-
84903643820
-
Generation of monoclonal antibodyproducing mammalian cell lines
-
Ho, S.C.L., Tong, Y.W., and Yang, Y. (2013) Generation of monoclonal antibodyproducing mammalian cell lines. Pharm. Bioprocess., 1, 71-87.
-
(2013)
Pharm. Bioprocess.
, vol.1
, pp. 71-87
-
-
Ho, S.C.L.1
Tong, Y.W.2
Yang, Y.3
-
47
-
-
67649625767
-
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin
-
Schwarzer, J., Rapp, E., Hennig, R., Genzel, Y. et al. (2009) Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine, 27, 4325-4336.
-
(2009)
Vaccine
, vol.27
, pp. 4325-4336
-
-
Schwarzer, J.1
Rapp, E.2
Hennig, R.3
Genzel, Y.4
-
48
-
-
67649979804
-
Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells
-
Zhirnov, O.P., Vorobjeva, I.V., Saphonova, O.A., Poyarkov, S.V. et al. (2009) Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J. Clin. Virol., 45, 322-333.
-
(2009)
J. Clin. Virol.
, vol.45
, pp. 322-333
-
-
Zhirnov, O.P.1
Vorobjeva, I.V.2
Saphonova, O.A.3
Poyarkov, S.V.4
-
49
-
-
56749106906
-
New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis
-
Chumakov, K. and Ehrenfeld, E. (2008) New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis. Clin. Infect. Dis., 47, 1587-1592.
-
(2008)
Clin. Infect. Dis.
, vol.47
, pp. 1587-1592
-
-
Chumakov, K.1
Ehrenfeld, E.2
-
50
-
-
84927109015
-
Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains
-
Hamidi, A. and Bakker, W.A.M. (2012) Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains. Pharm. Pat. Anal., 1, 589-599.
-
(2012)
Pharm. Pat. Anal.
, vol.1
, pp. 589-599
-
-
Hamidi, A.1
Bakker, W.A.M.2
-
51
-
-
0024315804
-
Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients
-
Wood, M.L., Katz, J.M., and Webster, R.G. (1989) Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology, 171, 275-279.
-
(1989)
Virology
, vol.171
, pp. 275-279
-
-
Wood, M.L.1
Katz, J.M.2
Webster, R.G.3
-
52
-
-
3242794938
-
Comparative study of influenza virus replication in Vero and MDCK cell lines
-
Youil, R., Su, Q., Toner, T.J., Szymkowiak, C. et al. (2004) Comparative study of influenza virus replication in Vero and MDCK cell lines. J. Virol. Meth., 120, 23-31.
-
(2004)
J. Virol. Meth.
, vol.120
, pp. 23-31
-
-
Youil, R.1
Su, Q.2
Toner, T.J.3
Szymkowiak, C.4
-
53
-
-
70350048935
-
Use of MDCK cells for production of live attenuated influenza vaccine
-
Liu, J., Shi, X., Schwartz, R., and Kemble, G. (2009) Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine, 27, 6460-6463.
-
(2009)
Vaccine
, vol.27
, pp. 6460-6463
-
-
Liu, J.1
Shi, X.2
Schwartz, R.3
Kemble, G.4
-
54
-
-
0032841887
-
Influence of hydrodynamic shear stress on microcarrier-attached cell growth: cell line dependency and surfactant protection
-
Wu, S.C. (1999) Influence of hydrodynamic shear stress on microcarrier-attached cell growth: cell line dependency and surfactant protection. Bioprocess Eng., 23, 201-206.
-
(1999)
Bioprocess Eng.
, vol.23
, pp. 201-206
-
-
Wu, S.C.1
-
55
-
-
0033796330
-
Hydrodynamic shear forces increase Japanese encephalitis virus production from microcarrier-grown Vero cells
-
Wu, S.C. and Huang, G.Y.L. (2000) Hydrodynamic shear forces increase Japanese encephalitis virus production from microcarrier-grown Vero cells. Bioprocess Eng., 23, 229-233;
-
(2000)
Bioprocess Eng.
, vol.23
, pp. 229-233
-
-
Wu, S.C.1
Huang, G.Y.L.2
-
56
-
-
0032619344
-
Production of influenza virus in serum-free mammalian cell cultures
-
discussion 73-74
-
Merten, O.-W., Manuguerra, J.C., Hannoun, C., and van der Werf, S. (1999) Production of influenza virus in serum-free mammalian cell cultures. Dev. Biol. Stand., 98, 23-37; discussion 73-74.
-
(1999)
Dev. Biol. Stand.
, vol.98
, pp. 23-37
-
-
Merten, O.-W.1
Manuguerra, J.C.2
Hannoun, C.3
van der Werf, S.4
-
57
-
-
0345721998
-
Development of Influenza Subunit Vaccine Produced using Mammalian Cell Culture Technology
-
eds M.J.T. Carrondo, B. Griffiths, and J.L.P. Moreira), Kluwer Academic Publishers, Dordrecht
-
Brands, R., Palache, A.M., and van Scharrenburg, G.J. (1997) Development of Influenza Subunit Vaccine Produced using Mammalian Cell Culture Technology, in Animal Cell Technology. From Vaccines to Genetic Medicine (eds M.J.T. Carrondo, B. Griffiths, and J.L.P. Moreira), Kluwer Academic Publishers, Dordrecht, pp. 165-167.
-
(1997)
Animal Cell Technology. From Vaccines to Genetic Medicine
, pp. 165-167
-
-
Brands, R.1
Palache, A.M.2
van Scharrenburg, G.J.3
-
58
-
-
77956225725
-
Non-tumorigenic MDCK cell line for propagating viruses
-
World pat. WO 2006/071563, filed 16 December 2005 and issued 6 July 2006
-
Schwartz, R., Berry, J.M., Subramanian, A., and Shi, X. (2006) Non-tumorigenic MDCK cell line for propagating viruses. World pat. WO 2006/071563, filed 16 December 2005 and issued 6 July 2006.
-
(2006)
-
-
Schwartz, R.1
Berry, J.M.2
Subramanian, A.3
Shi, X.4
-
59
-
-
0037081527
-
Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children
-
Halperin, S.A., Smith, B., Mabrouk, T., Germain, M. et al. (2002) Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine, 20, 1240-1247.
-
(2002)
Vaccine
, vol.20
, pp. 1240-1247
-
-
Halperin, S.A.1
Smith, B.2
Mabrouk, T.3
Germain, M.4
-
60
-
-
0032616689
-
Experience with vero cells at pasteur Mérieux connaught
-
discussion 167
-
Montagnon, B.J., Vincent-Falquet, J.C., and Saluzzo, J.F. (1999) Experience with vero cells at pasteur Mérieux connaught. Dev. Biol. Stand., 98, 137-140; discussion 167.
-
(1999)
Dev. Biol. Stand.
, vol.98
, pp. 137-140
-
-
Montagnon, B.J.1
Vincent-Falquet, J.C.2
Saluzzo, J.F.3
-
61
-
-
34447544007
-
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
-
Kistner,O., Howard, M.K., Spruth,M., Wodal,W. et al. (2007) Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine, 25, 6028-6036.
-
(2007)
Vaccine
, vol.25
, pp. 6028-6036
-
-
Kistner, O.1
Howard, M.K.2
Spruth, M.3
Wodal, W.4
-
62
-
-
0032616688
-
Development of a Vero cell-derived influenza whole virus vaccine
-
discussion 111
-
Kistner, O., Barrett, P.N., Mundt, W., Reiter, M. et al. (1999) Development of a Vero cell-derived influenza whole virus vaccine. Dev. Biol. Stand., 98, 101-110; discussion 111.
-
(1999)
Dev. Biol. Stand.
, vol.98
, pp. 101-110
-
-
Kistner, O.1
Barrett, P.N.2
Mundt, W.3
Reiter, M.4
-
63
-
-
77955656086
-
A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor
-
Lohr, V., Genzel, Y., Behrendt, I., Scharfenberg, K. et al. (2010) A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine, 28, 6256-6264.
-
(2010)
Vaccine
, vol.28
, pp. 6256-6264
-
-
Lohr, V.1
Genzel, Y.2
Behrendt, I.3
Scharfenberg, K.4
-
64
-
-
0035925715
-
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines
-
Pau,M.G., Ophorst, C., Koldijk, M.H., Schouten, G. et al. (2001) The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine, 19, 2716-2721.
-
(2001)
Vaccine
, vol.19
, pp. 2716-2721
-
-
Pau, M.G.1
Ophorst, C.2
Koldijk, M.H.3
Schouten, G.4
-
65
-
-
77953133120
-
Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing
-
Le Ru, A., Jacob, D., Transfiguracion, J., Ansorge, S. et al. (2010) Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine, 28, 3661-3671.
-
(2010)
Vaccine
, vol.28
, pp. 3661-3671
-
-
Le Ru, A.1
Jacob, D.2
Transfiguracion, J.3
Ansorge, S.4
-
66
-
-
84899925061
-
High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells
-
2014 Feb 25. pii: S0264-410X(14)00189-3. [Epub ahead of print
-
Genzel, Y., Vogel, T., Buck, J., Behrendt, I. et al. (2014) High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine, 2014 Feb 25. pii: S0264-410X(14)00189-3. doi: 10.1016/j.vaccine.2014.02.016. [Epub ahead of print]
-
(2014)
Vaccine
-
-
Genzel, Y.1
Vogel, T.2
Buck, J.3
Behrendt, I.4
-
67
-
-
84867900282
-
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells
-
Lohr, V., Genzel, Y., Jordan, I., Katinger, D. et al. (2012) Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol., 12, 79.
-
(2012)
BMC Biotechnol.
, vol.12
, pp. 79
-
-
Lohr, V.1
Genzel, Y.2
Jordan, I.3
Katinger, D.4
-
68
-
-
85192422290
-
Building on the unique biological properties of embryonic stem cells from the industrial manufacture of human and veterinary vaccines
-
Presented at the 3rd Annual IsBioTech Meeting, Rosslyn, VA, USA, 11-13 March
-
Mehtali, M. (2013) Building on the unique biological properties of embryonic stem cells from the industrial manufacture of human and veterinary vaccines. Presented at the 3rd Annual IsBioTech Meeting, Rosslyn, VA, USA, 11-13 March.
-
(2013)
-
-
Mehtali, M.1
-
69
-
-
0017645084
-
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail
-
Moscovici, C., Moscovici, M.G., Jimenez, H., Lai, M.M. et al. (1977) Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell, 11, 95-103.
-
(1977)
Cell
, vol.11
, pp. 95-103
-
-
Moscovici, C.1
Moscovici, M.G.2
Jimenez, H.3
Lai, M.M.4
-
70
-
-
49349085137
-
Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses
-
Lee, C.-W., Jung, K., Jadhao, S.J., and Suarez, D.L. (2006) Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses. J. Virol. Methods, 153, 22-28.
-
(2006)
J. Virol. Methods
, vol.153
, pp. 22-28
-
-
Lee, C.-W.1
Jung, K.2
Jadhao, S.J.3
Suarez, D.L.4
-
71
-
-
33747065024
-
Replacement of primary chicken embryonic fibroblasts (CEF) by the DF-1 cell line for detection of avian leucosis viruses
-
Maas, R., van Zoelen, D., Oei, H., and Claassen, I. (2006) Replacement of primary chicken embryonic fibroblasts (CEF) by the DF-1 cell line for detection of avian leucosis viruses. Biologicals, 34 (2006), 177-181.
-
(2006)
Biologicals
, vol.34
, Issue.2006
, pp. 177-181
-
-
Maas, R.1
van Zoelen, D.2
Oei, H.3
Claassen, I.4
-
72
-
-
33750380251
-
Permissibility of different cell types for the growth of avian metapneumovirus
-
Tiwari, A., Patnayak, D.P., Chander, Y., and Goyal, S.M. (2006) Permissibility of different cell types for the growth of avian metapneumovirus. J. Virol.Meth., 138, 80-84.
-
(2006)
J. Virol.Meth.
, vol.138
, pp. 80-84
-
-
Tiwari, A.1
Patnayak, D.P.2
Chander, Y.3
Goyal, S.M.4
-
73
-
-
0032619344
-
Production of influenza virus in serumfree mammalian cell cultures
-
discussion 73-74
-
Merten, O.-W., Manuguerra, J.C., Hannoun, C., and van der Werf, S. (1999) Production of influenza virus in serumfree mammalian cell cultures. Dev. Biol. Stand., 98, 23-37, discussion 73-74.
-
(1999)
Dev. Biol. Stand.
, vol.98
, pp. 23-37
-
-
Merten, O.-W.1
Manuguerra, J.C.2
Hannoun, C.3
van der Werf, S.4
-
74
-
-
56249091780
-
Visualizing the dynamics of viral replication in living cells via Tat peptide delivery of nucleaseresistant molecular beacons
-
A Yeh, H.Y., Yates, M.V., Mulchandani, A., and Chen, W. (2008) Visualizing the dynamics of viral replication in living cells via Tat peptide delivery of nucleaseresistant molecular beacons. Proc. Natl. Acad. Sci. USA, 105, 17522-17525.
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 17522-17525
-
-
Ayeh, H.Y.1
Yates, M.V.2
Mulchandani, A.3
Chen, W.4
-
75
-
-
84927058481
-
Production influenza virus vaccines
-
World pat. WO 2007/ 045674 filed 19 October 2006 and issued 26 April 2007
-
Uytdehaag, A.G.C.M., Pau, M.G., and Schouten, G. (2007) Production influenza virus vaccines. World pat. WO 2007/ 045674 filed 19 October 2006 and issued 26 April 2007.
-
(2007)
-
-
Uytdehaag, A.G.C.M.1
Pau, M.G.2
Schouten, G.3
-
76
-
-
61349200100
-
A phase I clinical trial of a PER. C61 cell grown influenza H7 virus vaccine
-
Cox, R.J., Madhun, A.S., Hauge, S., Sjursen, H. et al. (2009) A phase I clinical trial of a PER. C61 cell grown influenza H7 virus vaccine. Vaccine, 27, 1889-1897.
-
(2009)
Vaccine
, vol.27
, pp. 1889-1897
-
-
Cox, R.J.1
Madhun, A.S.2
Hauge, S.3
Sjursen, H.4
-
77
-
-
0033537974
-
Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium
-
Voeten, J.T., Brands, R., Palache, A.M., van Scharrenburg, G.J. et al. (1999) Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine, 17, 1942-1950.
-
(1999)
Vaccine
, vol.17
, pp. 1942-1950
-
-
Voeten, J.T.1
Brands, R.2
Palache, A.M.3
van Scharrenburg, G.J.4
-
78
-
-
85192407069
-
New cell line for viral vaccine manufacturing
-
Presented at the 22nd ESACT Meeting, Vienna/A, 15th-18th June 2011
-
Hebben, M. (2011) New cell line for viral vaccine manufacturing. Presented at the 22nd ESACT Meeting, Vienna/A, 15th-18th June 2011.
-
(2011)
-
-
Hebben, M.1
-
79
-
-
45849104841
-
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer
-
Gomez, C.E., Najera, J.L., Krupa, M., and Esteban, M. (2008) The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer. Curr. Gene Ther., 8, 97-120.
-
(2008)
Curr. Gene Ther.
, vol.8
, pp. 97-120
-
-
Gomez, C.E.1
Najera, J.L.2
Krupa, M.3
Esteban, M.4
-
80
-
-
78649369270
-
TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4: lessons learned and future development
-
Kim, D.W., Krishnamurthy, V., Bines, S.D., and Kaufman, H.L. (2010) TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4: lessons learned and future development. Hum. Vaccine, 6, 784-791.
-
(2010)
Hum. Vaccine
, vol.6
, pp. 784-791
-
-
Kim, D.W.1
Krishnamurthy, V.2
Bines, S.D.3
Kaufman, H.L.4
-
81
-
-
80051490030
-
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C
-
Habersetzer, F., Honnet, G., Bain, C., Maynard-Muet, M. et al. (2011) A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C. Gastroenterology, 141, 890-899.
-
(2011)
Gastroenterology
, vol.141
, pp. 890-899
-
-
Habersetzer, F.1
Honnet, G.2
Bain, C.3
Maynard-Muet, M.4
-
82
-
-
65449126737
-
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
-
Rimmelzwaan, G.F. and Sutter, G. (2009) Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. Expert Rev. Vaccines, 8, 447-454.
-
(2009)
Expert Rev. Vaccines
, vol.8
, pp. 447-454
-
-
Rimmelzwaan, G.F.1
Sutter, G.2
-
83
-
-
80052592683
-
Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever
-
Schafer, B., Holzer, G.W., Joachimsthaler, A., Coulibaly, S. et al. (2011) Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever. PLoS One, 6, e24505.
-
(2011)
PLoS One
, vol.6
, pp. e24505
-
-
Schafer, B.1
Holzer, G.W.2
Joachimsthaler, A.3
Coulibaly, S.4
-
84
-
-
4744366292
-
The prolonged coexistence of vaccinia virus in high titre and living cells in roller tube cultures of chick embryonic tissues
-
Feller, A.E., Enders, J.F., and Weller, T.H. (1940) The prolonged coexistence of vaccinia virus in high titre and living cells in roller tube cultures of chick embryonic tissues. J. Exp. Med., 72, 367-388.
-
(1940)
J. Exp. Med.
, vol.72
, pp. 367-388
-
-
Feller, A.E.1
Enders, J.F.2
Weller, T.H.3
-
86
-
-
79551549645
-
A chemically defined production process for highly attenuated poxvirus
-
Jordan, I., Northoff, S., Thiele, M., Hartmann, S. et al. (2011) A chemically defined production process for highly attenuated poxvirus. Biologicals, 39, 50-58.
-
(2011)
Biologicals
, vol.39
, pp. 50-58
-
-
Jordan, I.1
Northoff, S.2
Thiele, M.3
Hartmann, S.4
-
87
-
-
78650535419
-
Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
-
World pat. WO 2006/108846 A1 filed: 11 April 2006, published 19 October 2006
-
Mehtali, M., Chamion-Arnaud, P., and Leon, A. (2006) Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines. World pat. WO 2006/108846 A1 filed: 11 April 2006, published 19 October 2006.
-
(2006)
-
-
Mehtali, M.1
Chamion-Arnaud, P.2
Leon, A.3
-
88
-
-
85192406176
-
A novel genotype of MVA that efficiently replicates in single cell suspension
-
Presented at the 23rd ESACT Meeting, Lille/F, 23rd-26th, June 2013
-
Jordan, I. and Sandig, V. (2013) A novel genotype of MVA that efficiently replicates in single cell suspension. Presented at the 23rd ESACT Meeting, Lille/F, 23rd-26th, June 2013.
-
(2013)
-
-
Jordan, I.1
Sandig, V.2
-
89
-
-
84866899464
-
Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European Union
-
Ylä-Herttuala, S. (2012) Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European Union. Mol. Ther., 20, 1831-1832.
-
(2012)
Mol. Ther.
, vol.20
, pp. 1831-1832
-
-
Ylä-Herttuala, S.1
-
90
-
-
0017710978
-
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
-
Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36, 59-74.
-
(1977)
J. Gen. Virol.
, vol.36
, pp. 59-74
-
-
Graham, F.L.1
Smiley, J.2
Russell, W.C.3
Nairn, R.4
-
91
-
-
0029962803
-
Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors
-
Imler, J.L., Chartier, C., Dreyer, D., Dieterle, A. et al. (1996) Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther., 3, 75-84.
-
(1996)
Gene Ther.
, vol.3
, pp. 75-84
-
-
Imler, J.L.1
Chartier, C.2
Dreyer, D.3
Dieterle, A.4
-
92
-
-
17344373287
-
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses
-
Fallaux, F.J., Bout, A., van der Velde, I., van den Wollenberg, D.J. et al. (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther., 9, 1909-1917.
-
(1998)
Hum. Gene Ther.
, vol.9
, pp. 1909-1917
-
-
Fallaux, F.J.1
Bout, A.2
van der Velde, I.3
van den Wollenberg, D.J.4
-
93
-
-
0037215640
-
Production of adenovirus vector for gene therapy
-
Nadeau, I. and Kamen, A. (2003) Production of adenovirus vector for gene therapy. Biotechnol. Adv., 20, 475-489.
-
(2003)
Biotechnol. Adv.
, vol.20
, pp. 475-489
-
-
Nadeau, I.1
Kamen, A.2
-
94
-
-
0027525878
-
Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration of spatial distribution of viability
-
Peshwa, M.V., Kyung, Y.S., McClure, D.B., and Hu, W.S. (1993) Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration of spatial distribution of viability. Biotechnol. Bioeng., 41, 179-187.
-
(1993)
Biotechnol. Bioeng.
, vol.41
, pp. 179-187
-
-
Peshwa, M.V.1
Kyung, Y.S.2
McClure, D.B.3
Hu, W.S.4
-
95
-
-
0031554259
-
Inducing single-cell suspension of BTI-TN5B1-4 insect cells: I. The use of sulfated polyanions to prevent cell aggregation and enhance recombinant protein production
-
Dee, K.U., Shuler, M.L., and Wood, H.A. (1997) Inducing single-cell suspension of BTI-TN5B1-4 insect cells: I. The use of sulfated polyanions to prevent cell aggregation and enhance recombinant protein production. Biotechnol. Bioeng., 54, 191-205.
-
(1997)
Biotechnol. Bioeng.
, vol.54
, pp. 191-205
-
-
Dee, K.U.1
Shuler, M.L.2
Wood, H.A.3
-
96
-
-
85192418559
-
Method for the production and purification of adenoviral vectors
-
filed 20 November 1997 and issued 27 February 2001
-
Zhang, S., Thwin, C., Wu, Z., and Cho, T. (1997) Method for the production and purification of adenoviral vectors. US Pa. 6,194,191, filed 20 November 1997 and issued 27 February 2001.
-
(1997)
-
-
Zhang, S.1
Thwin, C.2
Wu, Z.3
Cho, T.4
-
97
-
-
0032899431
-
Comparison of manufacturing techniques for adenovirus production
-
Iyer, P., Ostrove, J.M., and Vacante, D. (1999) Comparison of manufacturing techniques for adenovirus production. Cytotechnology, 30, 169-172.
-
(1999)
Cytotechnology
, vol.30
, pp. 169-172
-
-
Iyer, P.1
Ostrove, J.M.2
Vacante, D.3
-
98
-
-
85192410052
-
Adenovirus production in 293 cells: a comparative study between a suspension cell and an adherent cell process
-
Presented at the 17th ESACT Meeting, Tylösand, Sweden, June 10-14, 2001
-
Nadeau, I., Seanez, G., and Wu, F. (2001) Adenovirus production in 293 cells: a comparative study between a suspension cell and an adherent cell process. Presented at the 17th ESACT Meeting, Tylösand, Sweden, June 10-14, 2001.
-
(2001)
-
-
Nadeau, I.1
Seanez, G.2
Wu, F.3
-
99
-
-
16344368861
-
A comparative study of large-scale production strategies used to produce RCA free adenovirus preparations in serum-free media
-
Research Report, JRH Bioscience, Lenexa, KS, USA
-
Irish, T., Baker, W., Fresner, B., Abraham, G. et al. (2000) A comparative study of large-scale production strategies used to produce RCA free adenovirus preparations in serum-free media. Research Report, JRH Bioscience, Lenexa, KS, USA.
-
(2000)
-
-
Irish, T.1
Baker, W.2
Fresner, B.3
Abraham, G.4
-
100
-
-
85192425748
-
Method of producing adenoviral vector stocks
-
filed 7 April 2000 and issued 2 January 2001
-
Liu, L.-C. and Shoupeng, L. (2002) Method of producing adenoviral vector stocks. US Pat. 6,168,941 B1, filed 7 April 2000 and issued 2 January 2001.
-
(2002)
-
-
Liu, L.-C.1
Shoupeng, L.2
-
101
-
-
85192399546
-
Serum-free media and bioreactor strategies for manufacturing adenoviral gene therapy vectors
-
Viral vectors. Viral vectors and vaccines, Lake Tahoe, NV, 6-9 November 2000
-
Chaubard, J.F. (2000) Serum-free media and bioreactor strategies for manufacturing adenoviral gene therapy vectors. Viral vectors. Viral vectors and vaccines, Lake Tahoe, NV, 6-9 November 2000.
-
(2000)
-
-
Chaubard, J.F.1
-
102
-
-
84927006917
-
Production of recombinant adenovirus by 293 cells cultures in perfusion
-
Cell Culture Engineering VIII, 1-6 April 2002, Snowmass, CO/USA
-
Garnier, A., Cortin, V., Thibault, J., and Jacob, D. (2002) Production of recombinant adenovirus by 293 cells cultures in perfusion. Cell Culture Engineering VIII, 1-6 April 2002, Snowmass, CO/USA.
-
(2002)
-
-
Garnier, A.1
Cortin, V.2
Thibault, J.3
Jacob, D.4
-
103
-
-
84927049947
-
Optimization of a 293 suspension process for adenovirus production
-
Cell Culture Engineering VIII, 1-6 April 2002, Snowmass, CO/USA
-
Nadeau, I., Seanez, G., and Wu, F. (2002) Optimization of a 293 suspension process for adenovirus production. Cell Culture Engineering VIII, 1-6 April 2002, Snowmass, CO/USA.
-
(2002)
-
-
Nadeau, I.1
Seanez, G.2
Wu, F.3
-
104
-
-
33745062611
-
Production and formulation of adenovirus vectors
-
Altaras, N.E., Aunins, J.G., Evans, R.K., Kamen, A. et al. (2005) Production and formulation of adenovirus vectors. Adv. Biochem. Eng. Biotechnol., 99, 193-260.
-
(2005)
Adv. Biochem. Eng. Biotechnol.
, vol.99
, pp. 193-260
-
-
Altaras, N.E.1
Aunins, J.G.2
Evans, R.K.3
Kamen, A.4
-
105
-
-
0037027820
-
Serum-free suspension cultivation of PER. C61 cells and recombinant adenovirus production under different pH conditions
-
Xie, L., Pilbrough, W., Metallo, C., Zhong, T. et al. (2002) Serum-free suspension cultivation of PER. C61 cells and recombinant adenovirus production under different pH conditions. Biotechnol. Bioeng., 80, 569-579.
-
(2002)
Biotechnol. Bioeng.
, vol.80
, pp. 569-579
-
-
Xie, L.1
Pilbrough, W.2
Metallo, C.3
Zhong, T.4
-
106
-
-
0037274197
-
pH, pCO2, and temperature effect on radenovirus production
-
Jardon, M. and Garnier, A. (2003) pH, pCO2, and temperature effect on radenovirus production. Biotechnol. Prog., 19, 202-208.
-
(2003)
Biotechnol. Prog.
, vol.19
, pp. 202-208
-
-
Jardon, M.1
Garnier, A.2
-
107
-
-
2942618534
-
Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures
-
Henry, O., Dormond, E., Perrier, M., and Kamen, A. (2004) Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol. Bioeng., 86, 765-777.
-
(2004)
Biotechnol. Bioeng.
, vol.86
, pp. 765-777
-
-
Henry, O.1
Dormond, E.2
Perrier, M.3
Kamen, A.4
-
108
-
-
84355161981
-
Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3)
-
Shen, C.F., Lanthier, S., Jacob, D., Montes, J. et al. (2012) Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3). Vaccine, 30, 300-306.
-
(2012)
Vaccine
, vol.30
, pp. 300-306
-
-
Shen, C.F.1
Lanthier, S.2
Jacob, D.3
Montes, J.4
-
109
-
-
84889794071
-
Methods for cultivating cells and propagating viruses
-
filed 5 October 2000 and issued 31 August 2004
-
Condon, R.G.G., Connelly, N.V., Frei, A., Glowacki, E. et al. (2000) Methods for cultivating cells and propagating viruses. US Pat. 6,783,983, filed 5 October 2000 and issued 31 August 2004.
-
(2000)
-
-
Condon, R.G.G.1
Connelly, N.V.2
Frei, A.3
Glowacki, E.4
-
110
-
-
12444331997
-
Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions
-
Xie, L., Metallo, C., Warren, J., Pilbrough, W. et al. (2003) Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions. Biotechnol. Bioeng., 83, 45-52.
-
(2003)
Biotechnol. Bioeng.
, vol.83
, pp. 45-52
-
-
Xie, L.1
Metallo, C.2
Warren, J.3
Pilbrough, W.4
-
111
-
-
24944454988
-
Current status of Gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers
-
Peng, Z. (2005) Current status of Gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther., 16, 1016-1027.
-
(2005)
Hum. Gene Ther.
, vol.16
, pp. 1016-1027
-
-
Peng, Z.1
-
112
-
-
0036811528
-
Production of clinical-grade recombinant adeno-associated virus vectors
-
Snyder, R.O. and Flotte, T.R. (2002) Production of clinical-grade recombinant adeno-associated virus vectors. Curr. Opin. Biotechnol., 13, 418-423.
-
(2002)
Curr. Opin. Biotechnol.
, vol.13
, pp. 418-423
-
-
Snyder, R.O.1
Flotte, T.R.2
-
113
-
-
0036428801
-
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
-
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y. et al. (2002) Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods, 28, 158-167.
-
(2002)
Methods
, vol.28
, pp. 158-167
-
-
Zolotukhin, S.1
Potter, M.2
Zolotukhin, I.3
Sakai, Y.4
-
114
-
-
0036430191
-
Production methods for gene transfer vectors based on adeno-associated virus serotypes
-
Grimm, D. (2002) Production methods for gene transfer vectors based on adeno-associated virus serotypes. Methods, 28, 146-157.
-
(2002)
Methods
, vol.28
, pp. 146-157
-
-
Grimm, D.1
-
115
-
-
27544445072
-
Current issues in adeno-associated viral vector production
-
Merten, O.W., Gény-Fiamma, C., and Douar, A.M. (2005) Current issues in adeno-associated viral vector production. Gene Ther., 12 (Suppl 1), S51-S61.
-
(2005)
Gene Ther.
, vol.12
, pp. S51-S61
-
-
Merten, O.W.1
Gény-Fiamma, C.2
Douar, A.M.3
-
116
-
-
0035229788
-
Optimised helper virus-free production of high-quality adeno-associated virus vectors
-
Drittanti, L., Jenny, C., Poulard, K., Samba, A. et al. (2001) Optimised helper virus-free production of high-quality adeno-associated virus vectors. J. Gene Med., 3, 59-71.
-
(2001)
J. Gene Med.
, vol.3
, pp. 59-71
-
-
Drittanti, L.1
Jenny, C.2
Poulard, K.3
Samba, A.4
-
117
-
-
0034530161
-
Scaling-up production of recombinant AAV vectors for clinical applications
-
Qu, G., McClelland, A., and Wright, J.F. (2000) Scaling-up production of recombinant AAV vectors for clinical applications. Curr. Opin. Drug Discov. Dev., 3, 750-755.
-
(2000)
Curr. Opin. Drug Discov. Dev.
, vol.3
, pp. 750-755
-
-
Qu, G.1
McClelland, A.2
Wright, J.F.3
-
118
-
-
13644268693
-
Optimization of production of adeno-associated virus (AAV) for use in gene therapy
-
Presented at: Cell Culture Engineering VI, San Diego, CA, 7-12 February 1998
-
Brown, P., Barrett, S., Godwin, S., Trudinger, M. et al. (1998) Optimization of production of adeno-associated virus (AAV) for use in gene therapy, Presented at: Cell Culture Engineering VI, San Diego, CA, 7-12 February 1998.
-
(1998)
-
-
Brown, P.1
Barrett, S.2
Godwin, S.3
Trudinger, M.4
-
119
-
-
33847074595
-
Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adenoassociated virus-beta-galactosidase reporter gene) production in suspensioncultured HEK-293 (human embryonic kidney 293) cells
-
Feng, L., Guo, M., Zhang, S., Chu, J. et al. (2007) Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adenoassociated virus-beta-galactosidase reporter gene) production in suspensioncultured HEK-293 (human embryonic kidney 293) cells. Biotechnol. Appl. Biochem., 46, 127-135.
-
(2007)
Biotechnol. Appl. Biochem.
, vol.46
, pp. 127-135
-
-
Feng, L.1
Guo, M.2
Zhang, S.3
Chu, J.4
-
120
-
-
34848876973
-
High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells
-
Hildinger, M., Baldi, L., Stettler, M., and Wurm, F.M. (2007) High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells. Biotechnol. Lett., 29, 1713-1721.
-
(2007)
Biotechnol. Lett.
, vol.29
, pp. 1713-1721
-
-
Hildinger, M.1
Baldi, L.2
Stettler, M.3
Wurm, F.M.4
-
121
-
-
34447636768
-
Scalable serum-free production of recombinant adenoassociated virus type 2 by transfection of 293 suspension cells
-
Durocher, Y., Pham, P.L., St-Laurent, G., Jacob, D. et al. (2007) Scalable serum-free production of recombinant adenoassociated virus type 2 by transfection of 293 suspension cells. J. Virol. Methods., 144, 32-40.
-
(2007)
J. Virol. Methods.
, vol.144
, pp. 32-40
-
-
Durocher, Y.1
Pham, P.L.2
St-Laurent, G.3
Jacob, D.4
-
122
-
-
33646543920
-
Scalable production of adenoassociated virus type 2 vectors via suspension transfection
-
Park, J.Y., Lim, B.P., Lee, K., Kim, Y.G. et al. (2006) Scalable production of adenoassociated virus type 2 vectors via suspension transfection. Biotechnol. Bioeng., 94, 416-430.
-
(2006)
Biotechnol. Bioeng.
, vol.94
, pp. 416-430
-
-
Park, J.Y.1
Lim, B.P.2
Lee, K.3
Kim, Y.G.4
-
123
-
-
84857602982
-
Adeno-associated virus vectorology, manufacturing, and clinical applications
-
Grieger, J.C. and Samulski, R.J. (2012) Adeno-associated virus vectorology, manufacturing, and clinical applications. Methods Enzymol., 507, 229-254.
-
(2012)
Methods Enzymol.
, vol.507
, pp. 229-254
-
-
Grieger, J.C.1
Samulski, R.J.2
-
124
-
-
0036111820
-
Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap
-
Gao, G.P., Lu, F., Sanmiguel, J.C., Tran, P.T. et al. (2002) Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap. Mol. Ther., 5, 644-649.
-
(2002)
Mol. Ther.
, vol.5
, pp. 644-649
-
-
Gao, G.P.1
Lu, F.2
Sanmiguel, J.C.3
Tran, P.T.4
-
125
-
-
0034218551
-
Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome
-
Chadeuf, G., Favre, D., Tessier, J., Provost, N. et al. (2000) Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J. Gene Med., 2, 260-268.
-
(2000)
J. Gene Med.
, vol.2
, pp. 260-268
-
-
Chadeuf, G.1
Favre, D.2
Tessier, J.3
Provost, N.4
-
126
-
-
0034295382
-
Selective rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines
-
Liu, X., Voulgaropoulou, F., Chen, R., Johnson, P.R. et al. (2000) Selective rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Mol. Ther., 2, 394-403.
-
(2000)
Mol. Ther.
, vol.2
, pp. 394-403
-
-
Liu, X.1
Voulgaropoulou, F.2
Chen, R.3
Johnson, P.R.4
-
127
-
-
0036366753
-
Recombinant adeno-associated viral vector production using stable packaging and producer cell lines
-
Mathews, L.C., Gray, J.T., Gallagher, M.R., and Snyder, R.O. (2002) Recombinant adeno-associated viral vector production using stable packaging and producer cell lines. Methods Enzymol., 346, 393-413.
-
(2002)
Methods Enzymol.
, vol.346
, pp. 393-413
-
-
Mathews, L.C.1
Gray, J.T.2
Gallagher, M.R.3
Snyder, R.O.4
-
128
-
-
20044363950
-
Development and characterization of a cell line for largescale, serum-free production of recombinant adeno-associated viral vectors
-
Farson, D., Harding, T.C., Tao, L., Liu, J. et al. (2004) Development and characterization of a cell line for largescale, serum-free production of recombinant adeno-associated viral vectors. J. Gene Med., 6, 1369-1381.
-
(2004)
J. Gene Med.
, vol.6
, pp. 1369-1381
-
-
Farson, D.1
Harding, T.C.2
Tao, L.3
Liu, J.4
-
129
-
-
15044351876
-
Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine
-
Tatalick, L.M., Gerard, C.J., Takeya, R., Price, D.N. et al. (2005) Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine. Vaccine, 23, 2628-2638.
-
(2005)
Vaccine
, vol.23
, pp. 2628-2638
-
-
Tatalick, L.M.1
Gerard, C.J.2
Takeya, R.3
Price, D.N.4
-
130
-
-
74949114697
-
Manufacturing recombinant adeno-associated viral vectors from producer cell clones
-
Thorne, B.A., Takeya, R.K., and Peluso, R.W. (2009) Manufacturing recombinant adeno-associated viral vectors from producer cell clones. Hum. Gene Ther., 20, 707-714.
-
(2009)
Hum. Gene Ther.
, vol.20
, pp. 707-714
-
-
Thorne, B.A.1
Takeya, R.K.2
Peluso, R.W.3
-
131
-
-
0030827207
-
Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap
-
Conway, J.E., Zolotukhin, S., Muzyczka, N., Hayward, G.S. et al. (1997) Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol., 71, 8780-8789.
-
(1997)
J. Virol.
, vol.71
, pp. 8780-8789
-
-
Conway, J.E.1
Zolotukhin, S.2
Muzyczka, N.3
Hayward, G.S.4
-
132
-
-
2642537075
-
Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids
-
Booth, M.J., Mistry, A., Li, X., Thrasher, A. et al. (2004) Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids. Gene Ther., 11, 829-837.
-
(2004)
Gene Ther.
, vol.11
, pp. 829-837
-
-
Booth, M.J.1
Mistry, A.2
Li, X.3
Thrasher, A.4
-
133
-
-
60449087086
-
An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes
-
Kang, W., Wang, L., Harrell, H., Liu, J. et al. (2009) An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes. Gene Ther., 16, 229-239.
-
(2009)
Gene Ther.
, vol.16
, pp. 229-239
-
-
Kang, W.1
Wang, L.2
Harrell, H.3
Liu, J.4
-
134
-
-
68949198072
-
Scalable recombinant adenoassociated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells
-
Thomas, D.L., Wang, L., Niamke, J., Liu, J. et al. (2009) Scalable recombinant adenoassociated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells. Hum. Gene Ther., 20, 861-870.
-
(2009)
Hum. Gene Ther.
, vol.20
, pp. 861-870
-
-
Thomas, D.L.1
Wang, L.2
Niamke, J.3
Liu, J.4
-
135
-
-
70449103126
-
A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields hightiter rAAV stocks from insect cells
-
Smith, R.H., Levy, J.R., and Kotin, R.M. (2009) A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields hightiter rAAV stocks from insect cells. Mol. Ther., 17, 1888-1896.
-
(2009)
Mol. Ther.
, vol.17
, pp. 1888-1896
-
-
Smith, R.H.1
Levy, J.R.2
Kotin, R.M.3
-
136
-
-
85192424739
-
Large scale AAV production for clinical trials for the treatment of neuromuscular diseases
-
Merten, O.-W. (2012) Large scale AAV production for clinical trials for the treatment of neuromuscular diseases. Hum. Gene Ther., 23, A21.
-
(2012)
Hum. Gene Ther.
, vol.23
, pp. A21
-
-
Merten, O.-W.1
-
137
-
-
68949210394
-
Large-scale adeno-associated viral vector production using a herpesvirusbased system enables manufacturing for clinical studies
-
Clément, N., Knop, D.R., and Byrne, B.J. (2009) Large-scale adeno-associated viral vector production using a herpesvirusbased system enables manufacturing for clinical studies. Hum. Gene Ther., 20, 796-806.
-
(2009)
Hum. Gene Ther.
, vol.20
, pp. 796-806
-
-
Clément, N.1
Knop, D.R.2
Byrne, B.J.3
-
138
-
-
85192421218
-
A1-7 Large Scale Production of AAV Vectors
-
ed. O. Cohen-Haguenauer), Editions EDK/Groupe EDP sciences, Paris
-
Merten, O.-W. and Moullier, P. (2012) A1-7 Large Scale Production of AAV Vectors, in Clinibook: Clinical Gene Transfer - Stateof-the-art (ed. O. Cohen-Haguenauer), Editions EDK/Groupe EDP sciences, Paris, pp. 71-82.
-
(2012)
Clinibook: Clinical Gene Transfer - Stateof-the-art
, pp. 71-82
-
-
Merten, O.-W.1
Moullier, P.2
-
139
-
-
80051969238
-
Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02-to 200-liter cultures
-
Cecchini, S., Virag, T., and Kotin, R.M. (2011) Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02-to 200-liter cultures. Hum. Gene Ther., 22, 1021-1030.
-
(2011)
Hum. Gene Ther.
, vol.22
, pp. 1021-1030
-
-
Cecchini, S.1
Virag, T.2
Kotin, R.M.3
-
140
-
-
0031710033
-
A third-generation lantivirus vector with a conditional packaging system
-
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J. et al. (1998) A third-generation lantivirus vector with a conditional packaging system. J. Virol., 72, 8463-8471.
-
(1998)
J. Virol.
, vol.72
, pp. 8463-8471
-
-
Dull, T.1
Zufferey, R.2
Kelly, M.3
Mandel, R.J.4
-
141
-
-
0031743608
-
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
-
Zufferey, R., Dull, T., Mandel, R.J., Bukovsky, A. et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol., 72, 9873-9880.
-
(1998)
J. Virol.
, vol.72
, pp. 9873-9880
-
-
Zufferey, R.1
Dull, T.2
Mandel, R.J.3
Bukovsky, A.4
-
143
-
-
70349909993
-
Lentiviral vectors in clinical trials
-
D'Costa, J., Mansfield, S.G., and Humeau, L.M. (2009) Lentiviral vectors in clinical trials. Curr. Opin. Mol. Ther., 11, 554-564.
-
(2009)
Curr. Opin. Mol. Ther.
, vol.11
, pp. 554-564
-
-
D'Costa, J.1
Mansfield, S.G.2
Humeau, L.M.3
-
144
-
-
84857623179
-
NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee
-
O'Reilly, M., Shipp, A., Rosenthal, E., Jambou, R. et al. (2012) NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee. Methods Enzymol., 507, 313-335.
-
(2012)
Methods Enzymol.
, vol.507
, pp. 313-335
-
-
O'Reilly, M.1
Shipp, A.2
Rosenthal, E.3
Jambou, R.4
-
145
-
-
35648981154
-
Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification
-
Segura, M.M., Garnier, A., Durocher, Y., Coelho, H. et al. (2007) Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol. Bioeng., 98, 789-799.
-
(2007)
Biotechnol. Bioeng.
, vol.98
, pp. 789-799
-
-
Segura, M.M.1
Garnier, A.2
Durocher, Y.3
Coelho, H.4
-
146
-
-
72449162211
-
Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures
-
Ansorge, S., Lanthier, S., Transfiguracion, J., Durocher, Y. et al. (2009) Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. J. Gene Med., 11, 868-876
-
(2009)
J. Gene Med.
, vol.11
, pp. 868-876
-
-
Ansorge, S.1
Lanthier, S.2
Transfiguracion, J.3
Durocher, Y.4
-
147
-
-
75349106422
-
Recent progress in lentiviral vector mass production
-
Ansorge, S., Henry, O., and Kamen, A. (2010) Recent progress in lentiviral vector mass production. Biochem. Eng. J., 48, 362-377.
-
(2010)
Biochem. Eng. J.
, vol.48
, pp. 362-377
-
-
Ansorge, S.1
Henry, O.2
Kamen, A.3
-
148
-
-
0037082158
-
High-level and high-throughput recombinant protein production by transient transfection of suspensiongrowing human 293-EBNA1 cells
-
Durocher, Y., Perret, S., and Kamen, A. (2002) High-level and high-throughput recombinant protein production by transient transfection of suspensiongrowing human 293-EBNA1 cells. Nucl. Acid. Res., 30, E9.
-
(2002)
Nucl. Acid. Res.
, vol.30
, pp. E9
-
-
Durocher, Y.1
Perret, S.2
Kamen, A.3
-
149
-
-
79952688973
-
Large scale manufacture and characterisation of a lentiviral vector produced for clinical ex vivo gene therapy application
-
Merten, O.-W., Charrier, S., Laroudie, N., Fauchille, S. et al. (2011) Large scale manufacture and characterisation of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum. Gene Ther., 22, 343-356.
-
(2011)
Hum. Gene Ther.
, vol.22
, pp. 343-356
-
-
Merten, O.-W.1
Charrier, S.2
Laroudie, N.3
Fauchille, S.4
-
150
-
-
79958259186
-
Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors
-
Lesch, H.P., Laitinen, A., Peixoto, C., Vicente, T. et al. (2011) Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther., 18, 531-538.
-
(2011)
Gene Ther.
, vol.18
, pp. 531-538
-
-
Lesch, H.P.1
Laitinen, A.2
Peixoto, C.3
Vicente, T.4
-
151
-
-
39849094316
-
Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture
-
Broussau, S., Jabbour, N., Lachapelle, G., Durocher, Y. et al. (2008) Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol. Ther., 16, 500-507.
-
(2008)
Mol. Ther.
, vol.16
, pp. 500-507
-
-
Broussau, S.1
Jabbour, N.2
Lachapelle, G.3
Durocher, Y.4
-
152
-
-
85192430686
-
Patent: Systéme baculovirus pour l'expression d'un vecteur de thérapie génique
-
FR, 1156878 - 1000119615 (27 July 2011)
-
Merten, O.-W., Galibert, L., and Jacob, A. (2011) Patent: Systéme baculovirus pour l'expression d'un vecteur de thérapie génique. FR, 1156878 - 1000119615 (27 July 2011).
-
(2011)
-
-
Merten, O.-W.1
Galibert, L.2
Jacob, A.3
-
153
-
-
51249098122
-
Generation of lentivirus vectors using recombinant baculoviruses
-
Lesch, H.P., Turpeinen, S., Niskanen, E.A., Mähönen, A.J. et al. (2008) Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther., 15, 1280-1286.
-
(2008)
Gene Ther.
, vol.15
, pp. 1280-1286
-
-
Lesch, H.P.1
Turpeinen, S.2
Niskanen, E.A.3
Mähönen, A.J.4
-
154
-
-
67149117119
-
Ef ficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
-
Throm, R.E., Ouma, A.A., Zhou, S., Chandrasekaran, A. et al. (2009) Ef ficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood, 113, 5104-5110.
-
(2009)
Blood
, vol.113
, pp. 5104-5110
-
-
Throm, R.E.1
Ouma, A.A.2
Zhou, S.3
Chandrasekaran, A.4
-
155
-
-
67349240866
-
Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
-
Stewart, H.J., Leroux-Carlucci, M.A., Sion, C.J., Mitrophanous, K.A. et al. (2009) Development of inducible EIAV-based lentiviral vector packaging and producer cell lines. Gene Ther., 16, 805-814.
-
(2009)
Gene Ther.
, vol.16
, pp. 805-814
-
-
Stewart, H.J.1
Leroux-Carlucci, M.A.2
Sion, C.J.3
Mitrophanous, K.A.4
-
156
-
-
78651300732
-
Large-scale production means for the manufacturing of lentiviral vectors
-
Schweizer, M. and Merten, O.-W. (2010) Large-scale production means for the manufacturing of lentiviral vectors. Curr. Gene Ther., 10, 474-486.
-
(2010)
Curr. Gene Ther.
, vol.10
, pp. 474-486
-
-
Schweizer, M.1
Merten, O.-W.2
-
157
-
-
0036412395
-
100-liter transient transfection
-
Girard, P., Derouazi, M., Baumgartner, G., Bourgeois, M. et al. (2002) 100-liter transient transfection. Cytotechnology, 38, 15 -21.
-
(2002)
Cytotechnology
, vol.38
, pp. 15 -21
-
-
Girard, P.1
Derouazi, M.2
Baumgartner, G.3
Bourgeois, M.4
-
158
-
-
0021776386
-
The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period
-
Radlett, P.J., Pay, T.W., and Garland, A.J. (1985) The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period. Dev. Biol. Stand., 60, 163-170.
-
(1985)
Dev. Biol. Stand.
, vol.60
, pp. 163-170
-
-
Radlett, P.J.1
Pay, T.W.2
Garland, A.J.3
-
159
-
-
0002692454
-
Introduction: Historical Perspectives
-
eds R.R. Granados and B.A. Federici), CRC Press, Boca Raton, FL
-
Benz, G.A. (1986) Introduction: Historical Perspectives, in The Biology of Baculoviruses. Volume I: Biological Properties and Molecular Biology (eds R.R. Granados and B.A. Federici), CRC Press, Boca Raton, FL, pp. 1-36.
-
(1986)
The Biology of Baculoviruses. Volume I: Biological Properties and Molecular Biology
, pp. 1-36
-
-
Benz, G.A.1
-
160
-
-
0032976453
-
Assessment of the application of baculoviruses for control of Lepidoptera
-
Moscardi, F. (1999) Assessment of the application of baculoviruses for control of Lepidoptera. Annu. Rev. Entomol., 44, 257-289.
-
(1999)
Annu. Rev. Entomol.
, vol.44
, pp. 257-289
-
-
Moscardi, F.1
-
161
-
-
0038000056
-
Cultivation of insect cells in airlift reactors: infl uence of reactor con figuration and superficial gas velocity
-
Visnovsky, G., Claus, J.D., and Merchuk, J.C. (2003) Cultivation of insect cells in airlift reactors: infl uence of reactor con figuration and superficial gas velocity. Lat. Am. Appl. Res., 33, 207-211.
-
(2003)
Lat. Am. Appl. Res.
, vol.33
, pp. 207-211
-
-
Visnovsky, G.1
Claus, J.D.2
Merchuk, J.C.3
-
162
-
-
84891016772
-
Production of Insecticidal Baculoviruses in Insect Cell Cultures: Potential and Limitations
-
eds. S. Soloneski and M. Larramendy), InTech, ch. 7
-
Claus, J.D., Gioria, V.V., Micheloud, G.A., and Visnovsky, G. (2012) Production of Insecticidal Baculoviruses in Insect Cell Cultures: Potential and Limitations, in Insecticides - Basic and other Applications (eds. S. Soloneski and M. Larramendy), InTech, ch. 7, pp. 127-152. ISBN 978-953-51-0007-2; doi: 10.5772/29551.
-
(2012)
Insecticides - Basic and other Applications
, pp. 127-152
-
-
Claus, J.D.1
Gioria, V.V.2
Micheloud, G.A.3
Visnovsky, G.4
-
163
-
-
0011697203
-
-
Books in Soils, Plants, and the Environment, vol. 78, Marcel Dekker, New York
-
Khetan, S.K. (2001) Microbial Pest Control, Books in Soils, Plants, and the Environment, vol. 78, Marcel Dekker, New York
-
(2001)
Microbial Pest Control
-
-
Khetan, S.K.1
-
164
-
-
84891027622
-
Characterization of growth and Oryctes rhinoceros nudivirus production in attached cultures of the DSIR-HA-1179 coleopteran insect cell line
-
Pushparajan, C., Claus, J.C., Marshall, S., and Visnovsky, G. (2013) Characterization of growth and Oryctes rhinoceros nudivirus production in attached cultures of the DSIR-HA-1179 coleopteran insect cell line. Cytotechnology, 65 (6), 1003-1016
-
(2013)
Cytotechnology
, vol.65
, Issue.6
, pp. 1003-1016
-
-
Pushparajan, C.1
Claus, J.C.2
Marshall, S.3
Visnovsky, G.4
-
165
-
-
85192421609
-
Towards a feasible process for the large scale production of Oryctes virus in DSIRHA-1179 insect cell cultures. Abstract at the 45th Annual Meeting of the Society for Invertebrate Pathology
-
International Congress on Invertebrate Pathology and Microbial Control, Buenos Aires, Argentina 5-9 August 2012, Available at, accessed 23 January 2014
-
Visnovsky, G.A., Claus, J.D., and Pushparajan, C. (2012) Towards a feasible process for the large scale production of Oryctes virus in DSIRHA-1179 insect cell cultures. Abstract at the 45th Annual Meeting of the Society for Invertebrate Pathology. International Congress on Invertebrate Pathology and Microbial Control, Buenos Aires, Argentina 5-9 August 2012, p. 79. Available at http://www.sipweb.org/docs/2012%20meeting%20program.pdf (accessed 23 January 2014).
-
(2012)
, pp. 79
-
-
Visnovsky, G.A.1
Claus, J.D.2
Pushparajan, C.3
-
166
-
-
0002063220
-
-
ed. L.K. Miller), Plenum Press, New York
-
Black, B.C., Brennan, L.A., Dierks, P.M., and Gard, I.E. (1997) Commercialization of Baculoviral Insecticides, The Baculoviruses (ed. L.K. Miller), Plenum Press, New York, pp. 341-387.
-
(1997)
Commercialization of Baculoviral Insecticides, The Baculoviruses
, pp. 341-387
-
-
Black, B.C.1
Brennan, L.A.2
Dierks, P.M.3
Gard, I.E.4
-
167
-
-
36048951318
-
Baculovirus insecticide production in insect larvae
-
van Beek, N. and Davis, D.C. (2007) Baculovirus insecticide production in insect larvae. Methods Mol. Biol., 388, 367-378.
-
(2007)
Methods Mol. Biol.
, vol.388
, pp. 367-378
-
-
van Beek, N.1
Davis, D.C.2
-
168
-
-
31744441864
-
Baculoviruses: re-emerging biopesticides
-
Szewczyk, B., Hoyos-Carvajal, L., Paluszek, M., Skrzecz, I. et al. (2006) Baculoviruses: re-emerging biopesticides. Biotechnol. Adv., 24, 143-160.
-
(2006)
Biotechnol. Adv.
, vol.24
, pp. 143-160
-
-
Szewczyk, B.1
Hoyos-Carvajal, L.2
Paluszek, M.3
Skrzecz, I.4
-
169
-
-
36048951317
-
Available lepidopteran cell lines
-
Lynn, D.E. (2007) Available lepidopteran cell lines. Methods Mol. Biol., 388, 117-137.
-
(2007)
Methods Mol. Biol.
, vol.388
, pp. 117-137
-
-
Lynn, D.E.1
-
170
-
-
0003609019
-
-
Oxford University Press, New York
-
ÓReilly, D.R., Miller, L.K., and Luckow, V.A. (1994) Baculovirus Expression Vectors. A Laboratory Manual, Oxford University Press, New York.
-
(1994)
Baculovirus Expression Vectors. A Laboratory Manual
-
-
ÓReilly, D.R.1
Miller, L.K.2
Luckow, V.A.3
-
171
-
-
0027362492
-
Anticarsia gemmatalis nuclear polyhedrosis virus replication in serum-free and serumreduced insect cell cultures
-
Claus, J.D., Remondetto, G.E., Guerrero, S.A., Demonte, A.M. et al. (1993) Anticarsia gemmatalis nuclear polyhedrosis virus replication in serum-free and serumreduced insect cell cultures. J. Biotechnol., 31, 1-15.
-
(1993)
J. Biotechnol.
, vol.31
, pp. 1-15
-
-
Claus, J.D.1
Remondetto, G.E.2
Guerrero, S.A.3
Demonte, A.M.4
-
172
-
-
0027430904
-
Effect of Trichoplusia ni BTI-Tn-5B1-4 cell density on human secreted alkaline phosphatase production
-
Chung, I.S. and Shuler, M.L. (1993) Effect of Trichoplusia ni BTI-Tn-5B1-4 cell density on human secreted alkaline phosphatase production. Biotechnol. Lett., 15, 1007-1012.
-
(1993)
Biotechnol. Lett.
, vol.15
, pp. 1007-1012
-
-
Chung, I.S.1
Shuler, M.L.2
-
173
-
-
0037560084
-
Insect cell culture for industrial production of recombinant proteins
-
Ikonomou, L., Schneider, Y.-J., and Agathos, S.N. (2003) Insect cell culture for industrial production of recombinant proteins. Appl. Microbiol. Biotechnol., 62, 1-20.
-
(2003)
Appl. Microbiol. Biotechnol.
, vol.62
, pp. 1-20
-
-
Ikonomou, L.1
Schneider, Y.-J.2
Agathos, S.N.3
-
174
-
-
32944454789
-
Enhancement of Sf9 cells and baculovirus production employing Grace's medium supplemented with milk whey ultrafiltrate
-
Batista, F.R.X., Pereira, C.A., MendonSca, R.Z., and Moraes, A.M. (2005) Enhancement of Sf9 cells and baculovirus production employing Grace's medium supplemented with milk whey ultrafiltrate. Cytotechnology, 49, 1-9.
-
(2005)
Cytotechnology
, vol.49
, pp. 1-9
-
-
Batista, F.R.X.1
Pereira, C.A.2
MendonSca, R.Z.3
Moraes, A.M.4
-
175
-
-
70349745705
-
Production of occlusion bodies of Anticarsia gemmatalis multiple nucleopolyhedrovirus in serumfree suspension cultures of the saUFL-AG-286 cell line: influence of infection conditions and statistical optimization
-
Micheloud, G.A., Gioria, V.V., Pérez, G., and Claus, J.D. (2009) Production of occlusion bodies of Anticarsia gemmatalis multiple nucleopolyhedrovirus in serumfree suspension cultures of the saUFL-AG-286 cell line: influence of infection conditions and statistical optimization. J. Virol. Methods, 162, 258-266.
-
(2009)
J. Virol. Methods
, vol.162
, pp. 258-266
-
-
Micheloud, G.A.1
Gioria, V.V.2
Pérez, G.3
Claus, J.D.4
-
176
-
-
0033094018
-
Yield, biological activity, and field performance of a wildtype Helicoverpa Nucleopolyhedrovirus produced in H. zea cell cultures
-
Chakraborty, S., Monsour, C., Teakle, R., and Reid, S. (1999) Yield, biological activity, and field performance of a wildtype Helicoverpa Nucleopolyhedrovirus produced in H. zea cell cultures. J. Invertebr. Pathol., 73, 199-205.
-
(1999)
J. Invertebr. Pathol.
, vol.73
, pp. 199-205
-
-
Chakraborty, S.1
Monsour, C.2
Teakle, R.3
Reid, S.4
-
177
-
-
28644450593
-
Cell culture derived AgMNPV bioinsecticide: biological constraints and bioprocess issues
-
Rodas, V.M., Marques, F.H., Honda, M.T., Soares, D.M. et al. (2005) Cell culture derived AgMNPV bioinsecticide: biological constraints and bioprocess issues. Cytotechnology, 48, 27-39.
-
(2005)
Cytotechnology
, vol.48
, pp. 27-39
-
-
Rodas, V.M.1
Marques, F.H.2
Honda, M.T.3
Soares, D.M.4
-
178
-
-
33947095897
-
Growth, metabolism and baculovirus production in suspension cultures of an Anticarsia gemmatalis cell line
-
Gioria, V.V., Jäger, V., and Claus, J.D. (2006) Growth, metabolism and baculovirus production in suspension cultures of an Anticarsia gemmatalis cell line. Cytotechnology, 52, 113-124.
-
(2006)
Cytotechnology
, vol.52
, pp. 113-124
-
-
Gioria, V.V.1
Jäger, V.2
Claus, J.D.3
-
179
-
-
0034793949
-
Identification of a Lymantria dispar nuclear polyhedrovirus isolate that does not accumulate fewpolyhedra mutants during extended serial passage in cell culture
-
Slavicek, J.M., Hayes-Plazolles, N., and Kelly, M.E. (2001) Identification of a Lymantria dispar nuclear polyhedrovirus isolate that does not accumulate fewpolyhedra mutants during extended serial passage in cell culture. Biol. Control, 22, 159-168.
-
(2001)
Biol. Control
, vol.22
, pp. 159-168
-
-
Slavicek, J.M.1
Hayes-Plazolles, N.2
Kelly, M.E.3
-
180
-
-
85192430829
-
Production of Gypchek in the Wave1 cell bioreactor: comparison to production in a stirred tank bioreactor, in Abstracts of 18th U.S
-
Department of Agriculture Interagency Research forum on Gypsy Moth and other Invasive Species 2007 (ed. K.W. Gottschalk), 2007 January 9-12, Annapolis, MD. Gen. Tech. Rep. NRS-P-28. U.S. Department of Agriculture, Forest Service, Northern Research, Station, Newtown Square, PA, Abstract
-
Slavicek, J.M. (2008) Production of Gypchek in the Wave1 cell bioreactor: comparison to production in a stirred tank bioreactor, in Abstracts of 18th U.S. Department of Agriculture Interagency Research forum on Gypsy Moth and other Invasive Species 2007 (ed. K.W. Gottschalk), 2007 January 9-12, Annapolis, MD. Gen. Tech. Rep. NRS-P-28. U.S. Department of Agriculture, Forest Service, Northern Research, Station, Newtown Square, PA, Abstract, p. 65.
-
(2008)
, pp. 65
-
-
Slavicek, J.M.1
-
181
-
-
85192398859
-
Production of LdMNPV in the Wave1 cell culture bioreactor, in Abstracts of 17th U.S
-
Department of Agriculture Interagency Research Forum on Gypsy Moth and Other Invasive Species 2006 (ed. K.W. Gottschalk), Gen. Tech. Rep. NRS-P-10. U.S. Department of Agriculture, Forest Service, Northern Research, Station, Newtown Square, PA
-
Slavicek, J.M. and Gabler, J.M. (2007) Production of LdMNPV in the Wave1 cell culture bioreactor, in Abstracts of 17th U.S. Department of Agriculture Interagency Research Forum on Gypsy Moth and Other Invasive Species 2006 (ed. K.W. Gottschalk), Gen. Tech. Rep. NRS-P-10. U.S. Department of Agriculture, Forest Service, Northern Research, Station, Newtown Square, PA, p. 91.
-
(2007)
, pp. 91
-
-
Slavicek, J.M.1
Gabler, J.M.2
-
183
-
-
20444434050
-
Bacteriophage Therapy in Humans
-
eds E. Kutter and A. Sulakvelidze), CRC Press, Boca Raton, FL
-
Sulakvelidze, A. and Kutter, E. (2005) Bacteriophage Therapy in Humans, in Bacteriophages: Biology and Application (eds E. Kutter and A. Sulakvelidze), CRC Press, Boca Raton, FL, pp. 381-436.
-
(2005)
Bacteriophages: Biology and Application
, pp. 381-436
-
-
Sulakvelidze, A.1
Kutter, E.2
-
185
-
-
77956627662
-
Bacteriophage applications: where are we now?
-
Monk, A., Rees, C., Barrow, P., Hagens, S. et al. (2010) Bacteriophage applications: where are we now? Lett. Appl. Microbiol., 51, 363-369.
-
(2010)
Lett. Appl. Microbiol.
, vol.51
, pp. 363-369
-
-
Monk, A.1
Rees, C.2
Barrow, P.3
Hagens, S.4
-
186
-
-
77950166515
-
Phage therapy in clinical practice: treatment of human infections
-
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z. et al. (2010) Phage therapy in clinical practice: treatment of human infections. Curr. Pharm. Biotechnol., 11, 69-86.
-
(2010)
Curr. Pharm. Biotechnol.
, vol.11
, pp. 69-86
-
-
Kutter, E.1
De Vos, D.2
Gvasalia, G.3
Alavidze, Z.4
-
187
-
-
85192416058
-
Soviet guidelines for production of liquid staphylococcal phage preparation for injections 29-86
-
(in Russian
-
Ministry of Health of the USSR (1986) Soviet guidelines for production of liquid staphylococcal phage preparation for injections 29-86 (in Russian).
-
(1986)
-
-
-
188
-
-
64049105821
-
Qualitycontrolled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials
-
Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N. et al. (2009) Qualitycontrolled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE, 4, e4944.
-
(2009)
PLoS ONE
, vol.4
, pp. e4944
-
-
Merabishvili, M.1
Pirnay, J.-P.2
Verbeken, G.3
Chanishvili, N.4
-
189
-
-
85192417853
-
Soviet guidelines for production of combined liquid pyobacteriophage preparation 242-82
-
in Russian
-
Ministry of Health of the USSR (1982) Soviet guidelines for production of combined liquid pyobacteriophage preparation 242-82 (in Russian).
-
(1982)
-
-
-
190
-
-
85192417874
-
Immunobiological bactericidal preparations (variations)
-
Russian pat. 2,366,708 C2 filed 29 October 2007 and issued 9 October 2009 (in Russian)
-
Aleshkin, V., Rubalskii, O., Afanasiev, S., Aleshkin, A. et al. (2007) Immunobiological bactericidal preparations (variations). Russian pat. 2,366,708 C2 filed 29 October 2007 and issued 9 October 2009 (in Russian).
-
(2007)
-
-
Aleshkin, V.1
Rubalskii, O.2
Afanasiev, S.3
Aleshkin, A.4
-
191
-
-
85192420918
-
Soviet guidelines for production of liquid streptococcal phage preparation 167-80
-
(in Russian
-
Ministry of Health of the USSR (1980) Soviet guidelines for production of liquid streptococcal phage preparation 167-80 (in Russian).
-
(1980)
-
-
-
192
-
-
85192422421
-
Soviet guidelines for production of typhoidal phage tablets with acid resistant covering
-
(in Russian
-
Ministry of Health of the USSR (1987) Soviet guidelines for production of typhoidal phage tablets with acid resistant covering 88 (in Russian).
-
(1987)
, vol.88
-
-
-
193
-
-
85192408978
-
Method for produce sanitation using bacteriophages
-
European pat. 1,250,053 A2 filed 11 January 2001and issued 23 October 2002
-
Alavidze, Z., Brown, T., Conway, W., Janisiewisz, W. et al. (2002) Method for produce sanitation using bacteriophages.European pat. 1,250,053 A2 filed 11 January 2001and issued 23 October 2002.
-
(2002)
-
-
Alavidze, Z.1
Brown, T.2
Conway, W.3
Janisiewisz, W.4
-
194
-
-
84905848608
-
Method of production of pyobacteriophage
-
Russian pat. 2,036,232 C1 filed 2 March 1992 and issued 27 May 1995 (in Russian).
-
Voroshilova, N., Kazakova, T., Gorbatkova, G., Bogovazova, G. et al. (1992) Method of production of pyobacteriophage. Russian pat. 2,036,232 C1 filed 2 March 1992 and issued 27 May 1995 (in Russian).
-
(1992)
-
-
Voroshilova, N.1
Kazakova, T.2
Gorbatkova, G.3
Bogovazova, G.4
-
195
-
-
84927100744
-
Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibioticresistant staphylococci
-
A1 filed 13 March 2009 and issued 20 January 2011
-
Müller, R. (2009) Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibioticresistant staphylococci. US pat. 0,014,157 A1 filed 13 March 2009 and issued 20 January 2011.
-
(2009)
-
-
Müller, R.1
-
196
-
-
0003159631
-
Methods of Study of Bacterial Viruses
-
ed. M.H. Adams), Interscience Publishers., New York
-
Adams, M.H. (1959) Methods of Study of Bacterial Viruses, in Bacteriophages (ed. M.H. Adams), Interscience Publishers., New York, pp. 443-522.
-
(1959)
Bacteriophages
, pp. 443-522
-
-
Adams, M.H.1
-
197
-
-
84927061731
-
Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
-
European pat. 1,406,642 B1, filed 18 July 2002 and issued 28 February 2007
-
Weber-Dabrowska, B., Mulczyk, M., Gorski, A., Boratynski, J. et al. (2002) Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections. European pat. 1,406,642 B1, filed 18 July 2002 and issued 28 February 2007.
-
(2002)
-
-
Weber-Dabrowska, B.1
Mulczyk, M.2
Gorski, A.3
Boratynski, J.4
-
198
-
-
85192401069
-
Polyvalent bacteriophage preparation against Pseudomonas aeruginosa, strains of P. aeruginosa N05, N03, N06 and N07 used for preparation of polyvalent bacteriophage preparation
-
Russian pat. 2,186,574 C1, filed 24 January 2001 and issued 10 August 2002 (in Russian).
-
Iafaev, R., Aslanov, B., and Zueva, L. (2001) Polyvalent bacteriophage preparation against Pseudomonas aeruginosa, strains of P. aeruginosa N05, N03, N06 and N07 used for preparation of polyvalent bacteriophage preparation. Russian pat. 2,186,574 C1, filed 24 January 2001 and issued 10 August 2002 (in Russian).
-
(2001)
-
-
Iafaev, R.1
Aslanov, B.2
Zueva, L.3
-
199
-
-
85192411187
-
Methods for evaluation of bacteriophage preparation
-
World pat. 059,161 A2, filed 17 December 2004 and issued 30 June 2005
-
Sulakvelidze, A., Sozhamamnnan, S., and Voelker, L. (2005) Methods for evaluation of bacteriophage preparation. World pat. 059,161 A2, filed 17 December 2004 and issued 30 June 2005.
-
(2005)
-
-
Sulakvelidze, A.1
Sozhamamnnan, S.2
Voelker, L.3
-
200
-
-
84927093475
-
Reduction in bacterial colonization by administrating bacteriophage compositions
-
B2, filed 2 December 2003 and issued 2 December 2008
-
Morris, J.G., Sulakvelidze, A., Alavidze, Z., Pasternack, G. et al. (2003) Reduction in bacterial colonization by administrating bacteriophage compositions. US pat. 7,459,272 B2, filed 2 December 2003 and issued 2 December 2008.
-
(2003)
-
-
Morris, J.G.1
Sulakvelidze, A.2
Alavidze, Z.3
Pasternack, G.4
-
201
-
-
84862843223
-
Le dosage du bactériophage
-
Appelmans, R. (1921) Le dosage du bactériophage. Compt. Rend. Soc. Biol., 85, 1098.
-
(1921)
Compt. Rend. Soc. Biol.
, vol.85
, pp. 1098
-
-
Appelmans, R.1
-
202
-
-
0009699788
-
Des relations numériques entre bactéries lysogenes et particules de bactériophage
-
Gratia, A. (1936) Des relations numériques entre bactéries lysogenes et particules de bactériophage. Ann. Inst. Pasteur, 57, 652-676.
-
(1936)
Ann. Inst. Pasteur
, vol.57
, pp. 652-676
-
-
Gratia, A.1
-
203
-
-
84927049944
-
Salmonella bacteriophage and uses thereof
-
filed 3 September 2004 and issued 9 March 2010
-
Sulakvelidze, A., Sozhamamnnan, S., and Pasternack, G. (2004) Salmonella bacteriophage and uses thereof. US pat. 7,674,467 B2, filed 3 September 2004 and issued 9 March 2010.
-
(2004)
-
-
Sulakvelidze, A.1
Sozhamamnnan, S.2
Pasternack, G.3
-
204
-
-
85192423071
-
Method of Brucella bacteriophage production
-
Russian pat. 2,249,616 C2, filed 6 June 2003 and issued 10 April 2005 (in Russian)
-
Liapustina, L., Liamkin, G., Tsigankova, R., Taran, I. et al. (2003) Method of Brucella bacteriophage production. Russian pat. 2,249,616 C2, filed 6 June 2003 and issued 10 April 2005 (in Russian).
-
(2003)
-
-
Liapustina, L.1
Liamkin, G.2
Tsigankova, R.3
Taran, I.4
-
205
-
-
85192413968
-
A Literature Review of the Practical Application of Bacteriophage Research
-
Nova Science Publishers, New York
-
Chanishvili, N. (2012) A Literature Review of the Practical Application of Bacteriophage Research, in Nova Biomedical Books, Nova Science Publishers, New York.
-
(2012)
Nova Biomedical Books
-
-
Chanishvili, N.1
-
206
-
-
80052078521
-
Optimization of lytic phage manufacturing in bioreactor using monolithic supports
-
Smrekar, F., Ciringer, M., Janĉar, J., Raspor, P. et al. (2011) Optimization of lytic phage manufacturing in bioreactor using monolithic supports. J. Sep. Sci., 34, 2152-2158.
-
(2011)
J. Sep. Sci.
, vol.34
, pp. 2152-2158
-
-
Smrekar, F.1
Ciringer, M.2
Janĉar, J.3
Raspor, P.4
-
207
-
-
85045329001
-
Process for continuous production of bacteriophage
-
filed 1 July 2011 and issued 16 February 2012
-
Baldwin, D. and Summer, N. (2011) Process for continuous production of bacteriophage. US pat. 0,040,329 A1, filed 1 July 2011 and issued 16 February 2012.
-
(2011)
-
-
Baldwin, D.1
Summer, N.2
-
208
-
-
85192429104
-
Preparation for treatment of pyoinflammatory diseases (variations)
-
Russian pat. 2,144,368 C1, filed 6 June 1997 and issued 20 January 2000 (in Russian).
-
Nigmatullin, T., Nasibulin, I., Iakubenko, N., Baiguzina, F. et al. (1997) Preparation for treatment of pyoinflammatory diseases (variations). Russian pat. 2,144,368 C1, filed 6 June 1997 and issued 20 January 2000 (in Russian).
-
(1997)
-
-
Nigmatullin, T.1
Nasibulin, I.2
Iakubenko, N.3
Baiguzina, F.4
-
209
-
-
84927009804
-
Production of bacteriophage compositions for use in phage therapy
-
filed 24 July 2006 and issued 11 January 2007
-
Bujanover, S. (2003) Production of bacteriophage compositions for use in phage therapy. US pat. 0,010,001 A1, filed 24 July 2006 and issued 11 January 2007.
-
(2003)
-
-
Bujanover, S.1
-
210
-
-
84927018659
-
Pharmaceutical composition, containing bacteriophages and method of preparation
-
Russian pat. 2,241,446 C2, filed 27 June 2002 and issued 20 January 2004 (in Russian)
-
Reshetnikov, V., Kazianin, A., Efimova, N., and Kameneva, M. (2002) Pharmaceutical composition, containing bacteriophages and method of preparation. Russian pat. 2,241,446 C2, filed 27 June 2002 and issued 20 January 2004 (in Russian).
-
(2002)
-
-
Reshetnikov, V.1
Kazianin, A.2
Efimova, N.3
Kameneva, M.4
-
211
-
-
85192427204
-
Process and system for the industrial scale purification of bacteriophages intended for bacteriophage therapy
-
European pat. 2,195,418 B1, filed 2 October 2007 and issued 12 December 2012
-
Lehnherr, H. and Bartsch, R. (2007) Process and system for the industrial scale purification of bacteriophages intended for bacteriophage therapy. European pat. 2,195,418 B1, filed 2 October 2007 and issued 12 December 2012.
-
(2007)
-
-
Lehnherr, H.1
Bartsch, R.2
-
212
-
-
85192432006
-
Purified bacteriophage, its preparation and application
-
filed 8 February 2008 and issued 13 January 2011
-
Lipinski, T., Gamian, A., Zuziak, E., Korzeniowska-Kowal, A. et al. (2011) Purified bacteriophage, its preparation and application. US pat. 0,008,873 A1, filed 8 February 2008 and issued 13 January 2011.
-
(2011)
-
-
Lipinski, T.1
Gamian, A.2
Zuziak, E.3
Korzeniowska-Kowal, A.4
-
213
-
-
85192427177
-
Bactericidal preparation
-
Russian pat. 1,704,462 C1, filed 9 January 1990 and issued 27 January 1995 (in Russian)
-
Nigmatullin, T., Viskova, R., Iakubenko, N., Nassibulin, I. et al. (1990) Bactericidal preparation. Russian pat. 1,704,462 C1, filed 9 January 1990 and issued 27 January 1995 (in Russian).
-
(1990)
-
-
Nigmatullin, T.1
Viskova, R.2
Iakubenko, N.3
Nassibulin, I.4
-
214
-
-
84905848609
-
Method for production of mono and combined dry bacteriophage preparation
-
Georgian pat. 20,063,943 B, filed 11 June 2003 and issued 10 October 2006 (in Georgian)
-
Meipariani, A., Alavidze, Z., Dzidzishvili, L., Chkonia, I. et al. (2003) Method for production of mono and combined dry bacteriophage preparation. Georgian pat. 20,063,943 B, filed 11 June 2003 and issued 10 October 2006 (in Georgian).
-
(2003)
-
-
Meipariani, A.1
Alavidze, Z.2
Dzidzishvili, L.3
Chkonia, I.4
-
215
-
-
84885549196
-
Polymer blends as biodegradable matrices for preparing biocomposites
-
European pat. 1,250,161 B1, filed 11 January 2001 and issued 21 December 2005
-
Katsarava, R. and Alavidze, Z. (2001) Polymer blends as biodegradable matrices for preparing biocomposites. European pat. 1,250,161 B1, filed 11 January 2001 and issued 21 December 2005.
-
(2001)
-
-
Katsarava, R.1
Alavidze, Z.2
-
216
-
-
68349154135
-
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
-
Wright, A., Hawkins, C., Anggárd, E., and Harper, D. (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol., 34, 349-357.
-
(2009)
Clin. Otolaryngol.
, vol.34
, pp. 349-357
-
-
Wright, A.1
Hawkins, C.2
Anggárd, E.3
Harper, D.4
-
217
-
-
80055108749
-
Phage therapy pharmacology: calculating phage dosing
-
Abedon, S. (2011) Phage therapy pharmacology: calculating phage dosing. Adv. Appl. Microbiol., 77, 1-40.
-
(2011)
Adv. Appl. Microbiol.
, vol.77
, pp. 1-40
-
-
Abedon, S.1
|